Krystal Biotech, Inc.
KRYS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001711279
In the last 90 days, Krystal Biotech, Inc. insiders filed 0 open-market purchases and 3 sales; 422 institutions reported holding it in 13F filings for Q2 2026, worth $11.1B in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Krystal Biotech, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 113 | 2 | 113 | +2 |
| Shares | 16.4M | 619.6K | 16.3M | +511.4K (+3.2%) |
| Value | $1.12B | $42.1M | $850.7M | −$222.4M (−20.7%) |
2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Krystal Biotech, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pictet Asset Management SA | 637,492 | $33.3M | 0.04% |
| Acuta Capital Partners, LLC | 72,551 | $3.79M | 1.35% |
| Ensign Peak Advisors, Inc | 34,596 | $1.81M | 0.00% |
| Renaissance Technologies LLC | 33,300 | $1.74M | 0.00% |
| Citadel Advisors LLC | 31,003 | $1.62M | 0.00% |
| Marshall Wace, LLP | 25,655 | $1.34M | 0.01% |
| Millennium Management LLC | 24,810 | $1.29M | 0.00% |
| Endurant Capital Management LP | 22,938 | $1.20M | 0.36% |
| Two Sigma Investments, LP | 10,683 | $558.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 3,960 | $207.0K | 0.00% |
| Advisor Group Holdings, Inc. | 619 | $32.0K | 0.00% |
| CSS LLC | 300 | $16.0K | 0.00% |
Sold out (10)
Institutions that held Krystal Biotech, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| FIL Ltd | 176,799 | $12.0M |
| Farallon Capital Management, L.L.C. | 75,000 | $5.10M |
| DSAM Partners (London) Ltd | 70,274 | $4.78M |
| Allianz Asset Management GmbH | 7,859 | $534.0K |
| Legato Capital Management LLC | 5,882 | $400.0K |
| Voloridge Investment Management, LLC | 5,604 | $381.0K |
| Dark Forest Capital Management LP | 318 | $22.0K |
| Walleye Trading LLC | 232 | $16.0K |
| TCI Wealth Advisors, Inc. | 38 | $3.00K |
| Whittier Trust Co | 25 | $2.00K |
Not filed for Q3 2021 yet (2)
Institutions that held Krystal Biotech, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pictet Asset Management Ltd | 557,480 | $37.9M |
| CWM, LLC | 62,112 | $4.22M |